• 1
    Hahn, B., Antibodies to DNA. New Engl. J. Med. 1998. 338: 13591368.
  • 2
    Ioannou, Y. and Isenberg, D. A., Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000. 43: 14311442.
  • 3
    Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L. and Notkins, A. L., Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 1979. 301: 58.
  • 4
    Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B. et al., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 2003. 100: 26102615.
  • 5
    Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. and Pascual, V., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003. 197: 711723.
  • 6
    Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B. et al., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med 2005. 202: 11311139.
  • 7
    Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S. et al., Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 2005. 202: 15751585.
  • 8
    Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R. et al., RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 2005. 202: 11711177.
  • 9
    Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J. and Marshak-Rothstein, A., Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002. 416: 603607.
  • 10
    Rozzo, S. J., Allard, J. D., Choubey, D., Vyse, T. J., Izui, S., Peltz, G. and Kotzin, B. L., Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001. 15: 435443.
  • 11
    Santiago-Raber, M. L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H. and Theofilopoulos, A. N., Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 2003. 197: 777788.
  • 12
    Mathian, A., Weinberg, A., Gallegos, M., Banchereau, J. and Koutouzov, S., IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J. Immunol. 2005. 174: 24992506.
  • 13
    Duramad, O., Fearon, K. L., Chang, B., Chan, J. H., Gregorio, J., Coffman, R. L. and Barrat, F. J., Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J. Immunol. 2005. 174: 51935200.
  • 14
    Marshak-Rothstein, A., Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006. 6: 823835.
  • 15
    Ronnblom, L. and Alm, G. V., Systemic lupus erythematosus and the type I interferon system. Arthritis Res. Ther. 2003. 5: 6875.
  • 16
    Shirota, H., Gursel, M. and Klinman, D. M., Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling. J. Immunol. 2004. 173: 50025007.
  • 17
    Duramad, O., Fearon, K. L., Chan, J. H., Kanzler, H., Marshall, J. D., Coffman, R. L. and Barrat, F. J., IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences. Blood 2003. 102: 44874492.